The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats

Lignende værker

• New Therapeutic Implications of Endothelial Nitric Oxide Synthase (eNOS) Function/Dysfunction in Cardiovascular Disease
  af: Daiber, Andreas, et al.
  Udgivet: (2019)
• The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity
  af: Oelze, Matthias, et al.
  Udgivet: (2014)
• Taking up the cudgels for the traditional reactive oxygen and nitrogen species detection assays and their use in the cardiovascular system
  af: Andreas Daiber, et al.
  Udgivet: (2017-08-01)
• Taking up the cudgels for the traditional reactive oxygen and nitrogen species detection assays and their use in the cardiovascular system
  af: Daiber, Andreas, et al.
  Udgivet: (2017)
• The Endothelin Receptor Antagonist Macitentan Improves Isosorbide-5-Mononitrate (ISMN) and Isosorbide Dinitrate (ISDN) Induced Endothelial Dysfunction, Oxidative Stress, and Vascular Inflammation
  af: Steven, Sebastian, et al.
  Udgivet: (2018)